WB
Western blot analysis using Nrf2 antibody against Hepg2 (1) cell lysate.
IHC
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissues using Nrf2 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal tissues using Nrf2 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal cancer tissues using Nrf2 antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human rectal cancer tissues using Nrf2 antibody with DAB staining.
WB
(B–D) Application of Western blot (B, C) and qT-PCR (D) to ascertain the protein and mRNA expression levels, respectively, in maternal placenta, liver, and pancreas tissues.
WB
(B, C) Western blotting analysis was used to detect theNrf2 and CBR1 expression level at week 0 and 16 in offspring rat liver (B) and pancreas (C).
WB
(A) BRL cells were exposed to 25-hydroxyvitaminD (VD3) at 0, 10, 100, 1,000 nM for 24 h, and thenNrf2 levels were evaluated by Western blot.
WB
(b–d) Western blot (b,c) and qRT-PCR (d) to ascertain the protein and mRNA expression levels in maternal placenta tissues.